Notably, no internal reference peptide or PSA glycopeptide could be detected in almost one third of the sample set (originally comprising 61 PBH and 38 PCa samples), determining the exclusion of these samples from subsequent data analysis. The gene discussed is KLK3; the disease is posterior cortical atrophy.